Mita, Monica M
Mita, Alain C
Moseley, Jennifer L
Poon, Jennifer
Small, Karen A
Jou, Ying-Ming
Kirschmeier, Paul
Zhang, Da
Zhu, Yali
Statkevich, Paul
Sankhala, Kamelesh K
Sarantopoulos, John
Cleary, James M
Chirieac, Lucian R
Rodig, Scott J
Bannerji, Rajat
Shapiro, Geoffrey I
Article History
Received: 3 March 2017
Revised: 15 June 2017
Accepted: 28 July 2017
First Online: 31 August 2017
Competing interests
: JP, KAS, Y-MJ, PK, DZ, YZ, PS, and RB are present or former employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. JMC has served as a consultant for Agios, received grants from Merck & Co., Inc., and received travel/ accommodations from Roche and Bristol Myers Squibb (BMS). LRC has served as a consultant for Wilcox & Savage, Medical Science Affiliates, and Shook, Hardy & Bacon, and has given expert testimony for Shook, Hardy & Bacon, and has received royalties from Springer. SR has served as a member of the board for Perkin Elmer Inc., has received grants from BMS, and has received payment for lectures from BMS. GIS has received consultant fees from Lilly, Pfizer, G1 Therapuetics, Vertex, and EMD Serono. His institution has received grants from Lilly and Pfizer. An SRA related to immunohistochemical staining of skin and tumour biopsies, under which there will be payment from Merck to the Brigham and Women’s Hospital for work completed, will be executed in relation to this work. All other authors declare no conflict of interest.